GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is Moderate Outperform.

The composite score behind that read is +0.21, weighing +0.35 of bullish evidence against -0.10 bearish.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) last closed at $46.50, -0.09% on the session.

Against the IVW growth benchmark the position is -0.89% over the forecast window.

The read is built from 15 underlying insights — 10 bullish and 5 bearish.

Agreement across those insights is 60%.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks GSK plc American Depositary Shares (Each representing two Ordinary Shares) in the 63rd percentile on valuation and the 86th percentile on return on equity, where 100 is best.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) is classified under Health Care / Pharmaceuticals, with a market capitalisation of $94.14B.

StockMap tracks GSK plc American Depositary Shares (Each representing two Ordinary Shares) as the 10th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite GSK plc American Depositary Shares (Each representing two Ordinary Shares) ranks 12th of 151 in the group, against a group median of -0.08.